-
1
-
-
0033916804
-
Epidemiology of hepatitis C: Geographic differences and temporal trends
-
10.1055/s-2000-9506 10895428
-
Epidemiology of hepatitis C: geographic differences and temporal trends. A Wasley MJ Alter, Semin Liver Dis 2000 20 1 16 10.1055/s-2000-9506 10895428
-
(2000)
Semin Liver Dis
, vol.20
, pp. 1-16
-
-
Wasley, A.1
Alter, M.J.2
-
2
-
-
16544379964
-
The epidemiology of acute and chronic hepatitis C
-
10.1016/S1089-3261(05)70321-4 15560058
-
The epidemiology of acute and chronic hepatitis C. MJ Alter, Clin Liver Dis 1997 1 559 568 10.1016/S1089-3261(05)70321-4 15560058
-
(1997)
Clin Liver Dis
, vol.1
, pp. 559-568
-
-
Alter, M.J.1
-
3
-
-
1542350630
-
NIH Consensus Statement on Management of Hepatitis C: 2002
-
NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 2002 19 1 46
-
(2002)
NIH Consens State Sci Statements
, vol.19
, pp. 1-46
-
-
-
4
-
-
33646250428
-
The natural history of hepatitis C virus (HCV) infection
-
16614742
-
The natural history of hepatitis C virus (HCV) infection. SL Chen TR Morgan, Int J Med Sci 2006 3 47 52 16614742
-
(2006)
Int J Med Sci
, vol.3
, pp. 47-52
-
-
Chen, S.L.1
Morgan, T.R.2
-
5
-
-
33947425672
-
The effects of HCV infection and management on health-related quality of life
-
DOI 10.1002/hep.21565
-
The effects of HCV infection and management on health-related quality of life. Z Younossi J Kallman J Kincaid, Hepatology 2007 45 806 816 10.1002/hep.21565 17326207 (Pubitemid 46450632)
-
(2007)
Hepatology
, vol.45
, Issue.3
, pp. 806-816
-
-
Younossi, Z.1
Kallman, J.2
Kincaid, J.3
-
6
-
-
34250621773
-
Hepatitis C virus: Virology, diagnosis and management of antiviral therapy
-
17552030
-
Hepatitis C virus: virology, diagnosis and management of antiviral therapy. S Chevaliez JM Pawlotsky, World J Gastroenterol 2007 13 2461 2466 17552030
-
(2007)
World J Gastroenterol
, vol.13
, pp. 2461-2466
-
-
Chevaliez, S.1
Pawlotsky, J.M.2
-
7
-
-
33644520948
-
Therapy of hepatitis C: From empiricism to eradication
-
DOI 10.1002/hep.21064
-
Therapy of hepatitis C: from empiricism to eradication. JM Pawlotsky, Hepatology 2006 43 S207 220 10.1002/hep.21064 16447262 (Pubitemid 43303984)
-
(2006)
Hepatology
, vol.43
, Issue.2 SUPPL. 1
-
-
Pawlotsky, J.-M.1
-
8
-
-
34247565001
-
Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C
-
DOI 10.1002/hep.21774
-
Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C. N Forestier HW Reesink CJ Weegink L McNair TL Kieffer HM Chu S Purdy PL Jansen S Zeuzem, Hepatology 2007 46 640 648 10.1002/hep.21774 17879366 (Pubitemid 47436108)
-
(2007)
Hepatology
, vol.46
, Issue.3
, pp. 640-648
-
-
Forestier, N.1
Reesink, H.W.2
Weegink, C.J.3
McNair, L.4
Kieffer, T.L.5
Chu, H.-M.6
Purdy, S.7
Jansen, P.L.M.8
Zeuzem, S.9
-
9
-
-
34548758435
-
Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients
-
DOI 10.1002/hep.21781
-
Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. TL Kieffer C Sarrazin JS Miller MW Welker N Forestier HW Reesink AD Kwong S Zeuzem, Hepatology 2007 46 631 639 10.1002/hep.21781 17680654 (Pubitemid 47436107)
-
(2007)
Hepatology
, vol.46
, Issue.3
, pp. 631-639
-
-
Kieffer, T.L.1
Sarrazin, C.2
Miller, J.S.3
Welker, M.W.4
Forestier, N.5
Reesink, H.W.6
Kwong, A.D.7
Zeuzem, S.8
-
11
-
-
33749360242
-
Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study
-
DOI 10.1053/j.gastro.2006.07.013, PII S0016508506015393
-
Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study. HW Reesink S Zeuzem CJ Weegink N Forestier A van Vliet J van de Wetering de Rooij L McNair S Purdy R Kauffman J Alam PL Jansen, Gastroenterology 2006 131 997 1002 10.1053/j.gastro.2006.07.013 17030169 (Pubitemid 44498690)
-
(2006)
Gastroenterology
, vol.131
, Issue.4
, pp. 997-1002
-
-
Reesink, H.W.1
Zeuzem, S.2
Weegink, C.J.3
Forestier, N.4
Van Vliet, A.5
Van De Wetering De Rooij, J.6
McNair, L.7
Purdy, S.8
Kauffman, R.9
Alam, J.10
Jansen, P.L.M.11
-
12
-
-
9644262469
-
Interferons, interferon-like cytokines, and their receptors
-
DOI 10.1111/j.0105-2896.2004.00204.x
-
Interferons, interferon-like cytokines, and their receptors. S Pestka CD Krause MR Walter, Immunol Rev 2004 202 8 32 10.1111/j.0105-2896.2004.00204.x 15546383 (Pubitemid 39576902)
-
(2004)
Immunological Reviews
, vol.202
, pp. 8-32
-
-
Pestka, S.1
Krause, C.D.2
Walter, M.R.3
-
13
-
-
0141860843
-
Mechanisms of action of interferon and nucleoside analogues
-
10.1016/S0168-8278(03)00207-1 14708685
-
Mechanisms of action of interferon and nucleoside analogues. H Thomas G Foster D Platis, J Hepatol 2003 39 Suppl 1 S93 98 10.1016/S0168-8278(03)00207-1 14708685
-
(2003)
J Hepatol
, vol.39
, Issue.SUPPL 1
, pp. 93-98
-
-
Thomas, H.1
Foster, G.2
Platis, D.3
-
14
-
-
0020629030
-
Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells
-
10.1016/0006-291X(83)91498-5 6303322
-
Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells. EN Fish K Banerjee N Stebbing, Biochem Biophys Res Commun 1983 112 537 546 10.1016/0006-291X(83)91498-5 6303322
-
(1983)
Biochem Biophys Res Commun
, vol.112
, pp. 537-546
-
-
Fish, E.N.1
Banerjee, K.2
Stebbing, N.3
-
15
-
-
0034767753
-
Antiviral actions of interferons
-
DOI 10.1128/CMR.14.4.778-809.2001
-
Antiviral actions of interferons. CE Samuel, Clin Microbiol Rev 2001 14 778 809 11585785 10.1128/CMR.14.4.778-809.2001 (Pubitemid 32979631)
-
(2001)
Clinical Microbiology Reviews
, vol.14
, Issue.4
, pp. 778-809
-
-
Samuel, C.E.1
-
16
-
-
0030467464
-
Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency
-
8974005
-
Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency. GR Foster O Rodrigues F Ghouze E Schulte-Frohlinde D Testa MJ Liao GR Stark L Leadbeater HC Thomas, J Interferon Cytokine Res 1996 16 1027 1033 8974005
-
(1996)
J Interferon Cytokine Res
, vol.16
, pp. 1027-1033
-
-
Foster, G.R.1
Rodrigues, O.2
Ghouze, F.3
Schulte-Frohlinde, E.4
Testa, D.5
Liao, M.J.6
Stark, G.R.7
Leadbeater, L.8
Thomas, H.C.9
-
17
-
-
0036787208
-
Different antiviral activities of IFN-alpha subtypes in human liver cell lines: Synergism between IFN-alpha2 and IFN-alpha8
-
10.1016/S1386-6346(02)00020-7 12270738
-
Different antiviral activities of IFN-alpha subtypes in human liver cell lines: synergism between IFN-alpha2 and IFN-alpha8. S Yamamoto H Yano O Sanou H Ikegami M Kurimoto M Kojiro, Hepatol Res 2002 24 99 10.1016/S1386-6346(02)00020- 7 12270738
-
(2002)
Hepatol Res
, vol.24
, pp. 99
-
-
Yamamoto, S.1
Yano, H.2
Sanou, O.3
Ikegami, H.4
Kurimoto, M.5
Kojiro, M.6
-
18
-
-
0345188811
-
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
-
DOI 10.1126/science.285.5424.110
-
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. V Lohmann F Korner J Koch U Herian L Theilmann R Bartenschlager, Science 1999 285 110 113 10.1126/science.285.5424.110 10390360 (Pubitemid 29307577)
-
(1999)
Science
, vol.285
, Issue.5424
, pp. 110-113
-
-
Lohmann, V.1
Korner, F.2
Koch, J.-O.3
Herian, U.4
Theilmann, L.5
Bartenschlager, R.6
-
19
-
-
30744461361
-
Divergent activities of interferon-alpha subtypes against intracellular hepatitis C virus replication
-
DOI 10.1016/j.hepres.2005.10.005, PII S1386634605003372
-
Divergent activities of interferon-alpha subtypes against intracellular hepatitis C virus replication. T Koyama N Sakamoto Y Tanabe M Nakagawa Y Itsui Y Takeda S Kakinuma Y Sekine S Maekawa Y Yanai, Hepatol Res 2006 34 41 49 10.1016/j.hepres.2005.10.005 16364683 (Pubitemid 43091875)
-
(2006)
Hepatology Research
, vol.34
, Issue.1
, pp. 41-49
-
-
Koyama, T.1
Sakamoto, N.2
Tanabe, Y.3
Nakagawa, M.4
Itsui, Y.5
Takeda, Y.6
Kakinuma, S.7
Sekine, Y.8
Maekawa, S.9
Yanai, Y.10
Kurimoto, M.11
Watanabe, M.12
-
20
-
-
22544470874
-
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
-
DOI 10.1038/nm1268
-
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. T Wakita T Pietschmann T Kato T Date M Miyamoto Z Zhao K Murthy A Habermann HG Krausslich M Mizokami, Nat Med 2005 11 791 796 10.1038/nm1268 15951748 (Pubitemid 41021213)
-
(2005)
Nature Medicine
, vol.11
, Issue.7
, pp. 791-796
-
-
Wakita, T.1
Pietschmann, T.2
Kato, T.3
Date, T.4
Miyamoto, M.5
Zhao, Z.6
Murthy, K.7
Habermann, A.8
Krausslich, H.-G.9
Mizokami, M.10
Bartenschlager, R.11
Liang, T.J.12
-
21
-
-
34247098497
-
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
-
DOI 10.1186/1743-422X-4-35
-
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies. C Fournier G Duverlie C Francois A Schnuriger S Dedeurwaerder E Brochot D Capron C Wychowski V Thibault S Castelain, Virol J 2007 4 35 17397531 10.1186/1743-422X-4-35 (Pubitemid 46597307)
-
(2007)
Virology Journal
, vol.4
, pp. 35
-
-
Fournier, C.1
Duverlie, G.2
Francois, C.3
Schnuriger, A.4
Dedeurwaerder, S.5
Brochot, E.6
Capron, D.7
Wychowski, C.8
Thibault, V.9
Castelain, S.10
-
22
-
-
4744360967
-
TaqMan amplification system with an internal positive control for HCV RNA quantitation
-
DOI 10.1016/j.jcv.2004.03.009, PII S1386653204000903
-
TaqMan amplification system with an internal positive control for HCV RNA quantitation. S Castelain V Descamps V Thibault C Francois D Bonte V Morel J Izopet D Capron P Zawadzki G Duverlie, J Clin Virol 2004 31 227 234 10.1016/j.jcv.2004.03.009 15465417 (Pubitemid 39311803)
-
(2004)
Journal of Clinical Virology
, vol.31
, Issue.3
, pp. 227-234
-
-
Castelain, S.1
Descamps, V.2
Thibault, V.3
Francois, C.4
Bonte, D.5
Morel, V.6
Izopet, J.7
Capron, D.8
Zawadzki, P.9
Duverlie, G.10
-
23
-
-
32944472275
-
Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array. Application to Hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma
-
DOI 10.2353/jmoldx.2006.040402
-
Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. A Steg W Wang C Blanquicett JM Grunda IA Eltoum K Wang DJ Buchsbaum SM Vickers S Russo RB Diasio, J Mol Diagn 2006 8 76 83 16436637 10.2353/jmoldx.2006.040402 (Pubitemid 43257437)
-
(2006)
Journal of Molecular Diagnostics
, vol.8
, Issue.1
, pp. 76-83
-
-
Steg, A.1
Wang, W.2
Blanquicett, C.3
Grunda, J.M.4
Eltoum, I.A.5
Wang, K.6
Buchsbaum, D.J.7
Vickers, S.M.8
Russo, S.9
Diasio, R.B.10
Frost, A.R.11
LoBuglio, A.F.12
Grizzle, W.E.13
Johnson, M.R.14
-
24
-
-
0035282841
-
Validation of an Mx/CAT reporter gene assay for the quantification of bovine type-I interferon
-
DOI 10.1016/S0022-1759(00)00359-8, PII S0022175900003598
-
Validation of an Mx/CAT reporter gene assay for the quantification of bovine type-I interferon. MD Fray GE Mann B Charleston, J Immunol Methods 2001 249 235 244 10.1016/S0022-1759(00)00359-8 11226480 (Pubitemid 32171975)
-
(2001)
Journal of Immunological Methods
, vol.249
, Issue.1-2
, pp. 235-244
-
-
Fray, M.D.1
Mann, G.E.2
Charleston, B.3
-
25
-
-
0032417696
-
Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
-
DOI 10.1073/pnas.95.26.15623
-
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. SD Der A Zhou BR Williams RH Silverman, Proc Natl Acad Sci USA 1998 95 15623 15628 9861020 10.1073/pnas.95.26.15623 (Pubitemid 29018750)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.26
, pp. 15623-15628
-
-
Der, S.D.1
Zhou, A.2
Williams, B.R.G.3
Silverman, R.H.4
-
26
-
-
19944430095
-
Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection
-
DOI 10.1016/j.virol.2004.11.009, PII S004268220400769X
-
Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. I Bieche T Asselah I Laurendeau D Vidaud C Degot V Paradis P Bedossa DC Valla P Marcellin M Vidaud, Virology 2005 332 130 144 10.1016/j.virol.2004.11.009 15661146 (Pubitemid 40127235)
-
(2005)
Virology
, vol.332
, Issue.1
, pp. 130-144
-
-
Bieche, I.1
Asselah, T.2
Laurendeau, I.3
Vidaud, D.4
Degot, C.5
Paradis, V.6
Bedossa, P.7
Valla, D.-C.8
Marcellin, P.9
Vidaud, M.10
-
27
-
-
34547752462
-
Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins
-
DOI 10.1093/carcin/bgm075
-
Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins. A Budhu Y Chen JW Kim M Forgues K Valerie CC Harris XW Wang, Carcinogenesis 2007 28 1552 1560 10.1093/carcin/bgm075 17404395 (Pubitemid 47241805)
-
(2007)
Carcinogenesis
, vol.28
, Issue.7
, pp. 1552-1560
-
-
Budhu, A.1
Chen, Y.2
Kim, J.W.3
Forgues, M.4
Valerie, K.5
Harris, C.C.6
Wang, X.W.7
-
28
-
-
34547775032
-
Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity
-
17713164
-
Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity. E Brochot G Duverlie S Castelain V Morel C Wychowski J Dubuisson C Francois, Antivir Ther 2007 12 805 813 17713164
-
(2007)
Antivir Ther
, vol.12
, pp. 805-813
-
-
Brochot, E.1
Duverlie, G.2
Castelain, S.3
Morel, V.4
Wychowski, C.5
Dubuisson, J.6
Francois, C.7
-
29
-
-
33845269751
-
Novel alpha interferon (IFN-α) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-α2b therapy in a subgenomic replicon system
-
DOI 10.1128/AAC.00199-06
-
Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system. V Escuret A Martin D Durantel R Parent O Hantz C Trepo T Menguy E Bottius J Dardy J Maral, Antimicrob Agents Chemother 2006 50 3984 3991 17030563 10.1128/AAC.00199-06 (Pubitemid 44865139)
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, Issue.12
, pp. 3984-3991
-
-
Escuret, V.1
Martin, A.2
Durantel, D.3
Parent, R.4
Hantz, O.5
Trepo, C.6
Menguy, T.7
Bottius, E.8
Dardy, J.9
Maral, J.10
Escary, J.L.11
Zoulim, F.12
-
30
-
-
33644522358
-
Inquiring into the differential action of interferons (IFNs): An IFN-α2 mutant with enhanced affinity to IFNAR1 Is functionally similar to IFN-β
-
DOI 10.1128/MCB.26.5.1888-1897.2006
-
Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. DA Jaitin LC Roisman E Jaks M Gavutis J Piehler J Van der Heyden G Uze G Schreiber, Mol Cell Biol 2006 26 1888 1897 16479007 10.1128/MCB.26.5.1888- 1897.2006 (Pubitemid 43297418)
-
(2006)
Molecular and Cellular Biology
, vol.26
, Issue.5
, pp. 1888-1897
-
-
Jaitin, D.A.1
Roisman, L.C.2
Jaks, E.3
Gavutis, M.4
Piehler, J.5
Van Der Heyden, J.6
Uze, G.7
Schreiber, G.8
-
31
-
-
0034704093
-
New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface
-
DOI 10.1074/jbc.M006854200
-
New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J Piehler LC Roisman G Schreiber, J Biol Chem 2000 275 40425 40433 10.1074/jbc.M006854200 10984492 (Pubitemid 32064677)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.51
, pp. 40425-40433
-
-
Piehler, J.1
Roisman, L.C.2
Schreiber, G.3
-
32
-
-
25144452720
-
Mutational analysis of the IFNAR1 binding site on IFNα2 reveals the architecture of a weak ligand-receptor binding-site
-
DOI 10.1016/j.jmb.2005.08.042, PII S0022283605009794
-
Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site. LC Roisman DA Jaitin DP Baker G Schreiber, J Mol Biol 2005 353 271 281 10.1016/j.jmb.2005.08.042 16171819 (Pubitemid 41356611)
-
(2005)
Journal of Molecular Biology
, vol.353
, Issue.2
, pp. 271-281
-
-
Roisman, L.C.1
Jaitin, D.A.2
Baker, D.P.3
Schreiber, G.4
-
33
-
-
35248864005
-
A structural basis for interferon-alpha-receptor interactions
-
10.1096/fj.07-8585com 17517919
-
A structural basis for interferon-alpha-receptor interactions. J Kumaran L Wei LP Kotra EN Fish, Faseb J 2007 21 3288 3296 10.1096/fj.07-8585com 17517919
-
(2007)
Faseb J
, vol.21
, pp. 3288-3296
-
-
Kumaran, J.1
Wei, L.2
Kotra, L.P.3
Fish, E.N.4
-
34
-
-
33745966693
-
Variations in the Unstructured C-terminal Tail of Interferons Contribute to Differential Receptor Binding and Biological Activity
-
DOI 10.1016/j.jmb.2006.05.069, PII S0022283606006875
-
Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity. M Slutzki DA Jaitin TB Yehezkel G Schreiber, J Mol Biol 2006 360 1019 1030 10.1016/j.jmb.2006.05.069 16815442 (Pubitemid 44062519)
-
(2006)
Journal of Molecular Biology
, vol.360
, Issue.5
, pp. 1019-1030
-
-
Slutzki, M.1
Jaitin, D.A.2
Yehezkel, T.B.3
Schreiber, G.4
-
35
-
-
33748450379
-
Complex Modulation of Cell Type-Specific Signaling in Response to Type I Interferons
-
DOI 10.1016/j.immuni.2006.08.014, PII S1074761306003992
-
Complex modulation of cell type-specific signaling in response to type I interferons. AH van Boxel-Dezaire MR Rani GR Stark, Immunity 2006 25 361 372 10.1016/j.immuni.2006.08.014 16979568 (Pubitemid 44354225)
-
(2006)
Immunity
, vol.25
, Issue.3
, pp. 361-372
-
-
Van Boxel-Dezaire, A.H.H.1
Rani, M.R.S.2
Stark, G.R.3
-
36
-
-
24144491592
-
Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation
-
DOI 10.1128/AAC.49.9.3770-3775.2005
-
Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation. C Francois I Bernard S Castelain B Charleston MD Fray JC Capiod G Duverlie, Antimicrob Agents Chemother 2005 49 3770 3775 16127052 10.1128/AAC.49.9.3770-3775.2005 (Pubitemid 41233030)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.9
, pp. 3770-3775
-
-
Francois, C.1
Bernard, I.2
Castelain, S.3
Charleston, B.4
Fray, M.D.5
Capiod, J.-C.6
Duverlie, G.7
-
37
-
-
0025331030
-
Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein
-
2161946
-
Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Pavlovic T Zurcher O Haller P Staeheli, J Virol 1990 64 3370 3375 2161946
-
(1990)
J Virol
, vol.64
, pp. 3370-3375
-
-
Pavlovic, J.1
Zurcher, T.2
Haller, O.3
Staeheli, P.4
-
38
-
-
0026929934
-
Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth
-
1382142
-
Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. EF Meurs Y Watanabe S Kadereit GN Barber MG Katze K Chong BR Williams AG Hovanessian, J Virol 1992 66 5805 5814 1382142
-
(1992)
J Virol
, vol.66
, pp. 5805-5814
-
-
Meurs, E.F.1
Watanabe, Y.2
Kadereit, S.3
Barber, G.N.4
Katze, M.G.5
Chong, K.6
Williams, B.R.7
Hovanessian, A.G.8
-
39
-
-
0025167232
-
A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication
-
DOI 10.1016/0042-6822(90)90292-Y
-
A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. EM Coccia G Romeo A Nissim G Marziali R Albertini E Affabris A Battistini G Fiorucci R Orsatti GB Rossi, Virology 1990 179 228 233 10.1016/0042-6822(90)90292-Y 2171206 (Pubitemid 20354334)
-
(1990)
Virology
, vol.179
, Issue.1
, pp. 228-233
-
-
Coccia, E.M.1
Romeo, G.2
Nissim, A.3
Marziali, G.4
Albertini, R.5
Affabris, E.6
Battistini, A.7
Fiorucci, G.8
Orsatti, R.9
Rossi, G.B.10
Chebath, J.11
-
40
-
-
34250643546
-
The interferon inducing pathways and the hepatitis C virus
-
17552028
-
The interferon inducing pathways and the hepatitis C virus. EF Meurs A Breiman, World J Gastroenterol 2007 13 2446 2454 17552028
-
(2007)
World J Gastroenterol
, vol.13
, pp. 2446-2454
-
-
Meurs, E.F.1
Breiman, A.2
|